Literature DB >> 32682565

Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences.

Pontus Plavén-Sigray1, Granville J Matheson2, Jennifer M Coughlin3, Sina Hafizi4, Heikki Laurikainen5, Julie Ottoy5, Livia De Picker6, Pablo Rusjan4, Jarmo Hietala7, Oliver D Howes8, Romina Mizrahi4, Manuel Morrens6, Martin G Pomper3, Simon Cervenka9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32682565      PMCID： PMC7899168          DOI： 10.1016/j.biopsych.2020.05.028

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  32 in total

Review 1.  Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders.

Authors:  Richard Banati; Ian B Hickie
Journal:  Med J Aust       Date:  2009-02-16       Impact factor: 7.738

2.  Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?: A commentary on 'Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging' by Marques et al. - ERRATUM.

Authors:  P Plavén-Sigray; S Cervenka
Journal:  Psychol Med       Date:  2019-04-30       Impact factor: 7.723

3.  Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?

Authors:  Marjolein A M Sneeboer; Thalia van der Doef; Manja Litjens; N B B Psy; J Melief; Elly M Hol; René S Kahn; Lot D de Witte
Journal:  Schizophr Res       Date:  2019-11-04       Impact factor: 4.939

4.  Neuroinflammation in schizophrenia-related psychosis: a PET study.

Authors:  Janine Doorduin; Erik F J de Vries; Antoon T M Willemsen; Jan Cees de Groot; Rudi A Dierckx; Hans C Klein
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

5.  Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios.

Authors:  Masahiro Fujita; Masato Kobayashi; Masamichi Ikawa; Roger N Gunn; Eugenii A Rabiner; David R Owen; Sami S Zoghbi; Mohamad B Haskali; Sanjay Telu; Victor W Pike; Robert B Innis
Journal:  EJNMMI Res       Date:  2017-10-16       Impact factor: 3.138

6.  Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Authors:  Pontus Plavén-Sigray; Granville James Matheson; Zsolt Cselényi; Aurelija Jucaite; Lars Farde; Simon Cervenka
Journal:  EJNMMI Res       Date:  2018-11-29       Impact factor: 3.138

7.  Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Authors:  Pontus Plavén-Sigray; Granville J Matheson; Karin Collste; Abhishekh H Ashok; Jennifer M Coughlin; Oliver D Howes; Romina Mizrahi; Martin G Pomper; Pablo Rusjan; Mattia Veronese; Yuchuan Wang; Simon Cervenka
Journal:  Biol Psychiatry       Date:  2018-03-06       Impact factor: 13.382

8.  In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma.

Authors:  J M Coughlin; Y Wang; E B Ambinder; R E Ward; I Minn; M Vranesic; P K Kim; C N Ford; C Higgs; L N Hayes; D J Schretlen; R F Dannals; M Kassiou; A Sawa; M G Pomper
Journal:  Transl Psychiatry       Date:  2016-04-12       Impact factor: 6.222

9.  PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

Authors:  M A Di Biase; A Zalesky; G O'keefe; L Laskaris; B T Baune; C S Weickert; J Olver; P D McGorry; G P Amminger; B Nelson; A M Scott; I Hickie; R Banati; F Turkheimer; M Yaqub; I P Everall; C Pantelis; V Cropley
Journal:  Transl Psychiatry       Date:  2017-08-29       Impact factor: 6.222

Review 10.  Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.

Authors:  Tiago Reis Marques; Abhishekh H Ashok; Toby Pillinger; Mattia Veronese; Federico E Turkheimer; Paola Dazzan; Iris E C Sommer; Oliver D Howes
Journal:  Psychol Med       Date:  2018-10-25       Impact factor: 10.592
View more
  9 in total

Review 1.  Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

Authors:  Jeffrey H Meyer; Simon Cervenka; Min-Jeong Kim; William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Lancet Psychiatry       Date:  2020-10-21       Impact factor: 27.083

2.  The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis.

Authors:  M Morrens; C Overloop; V Coppens; E Loots; M Van Den Noortgate; S Vandenameele; M Leboyer; L De Picker
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

Review 3.  Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry.

Authors:  David S Thylur; David R Goldsmith
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

Review 4.  Application of positron emission tomography in psychiatry-methodological developments and future directions.

Authors:  Simon Cervenka; Andreas Frick; Robert Bodén; Mark Lubberink
Journal:  Transl Psychiatry       Date:  2022-06-14       Impact factor: 7.989

5.  Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial.

Authors:  Iris E Sommer; Shiral S Gangadin; Lot D de Witte; Sanne Koops; C van Baal; Sabine Bahn; Hemmo Drexhage; N E M van Haren; Wim Veling; R Bruggeman; Peter Martens; Sybren Wiersma; Selene R T Veerman; Koen P Grootens; Nico van Beveren; Rene S Kahn; Marieke J H Begemann
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

6.  Microglia Loss and Astrocyte Activation Cause Dynamic Changes in Hippocampal [18F]DPA-714 Uptake in Mouse Models of Depression.

Authors:  Jiamei Guo; Tian Qiu; Lixia Wang; Lei Shi; Ming Ai; Zhu Xia; Zhiping Peng; Anhai Zheng; Xiao Li; Li Kuang
Journal:  Front Cell Neurosci       Date:  2022-02-18       Impact factor: 5.505

7.  Meta-analysis of molecular imaging of translocator protein in major depression.

Authors:  Benjamin Eggerstorfer; Jong-Hoon Kim; Paul Cumming; Rupert Lanzenberger; Gregor Gryglewski
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

Review 8.  Cellular sources of TSPO expression in healthy and diseased brain.

Authors:  Erik Nutma; Kelly Ceyzériat; Sandra Amor; Stergios Tsartsalis; Philippe Millet; David R Owen; Vassilios Papadopoulos; Benjamin B Tournier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-12       Impact factor: 9.236

Review 9.  Immune environment of the brain in schizophrenia and during the psychotic episode: A human post-mortem study.

Authors:  Livia J De Picker; Gerardo Mendez Victoriano; Rhys Richards; Alexander J Gorvett; Simeon Lyons; George R Buckland; Tommaso Tofani; Jeanette L Norman; David S Chatelet; James A R Nicoll; Delphine Boche
Journal:  Brain Behav Immun       Date:  2021-07-30       Impact factor: 7.217
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.